Behcet's syndrome: one year in review 2022

Creative Commons License

Hatemi G., SEYAHİ E., Fresko I., Talarico R., Ucar D., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.40, sa.8, ss.1461-1471, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 40 Sayı: 8
  • Basım Tarihi: 2022
  • Doi Numarası: 10.55563/clinexprheumatol/h4dkrs
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, Veterinary Science Database
  • Sayfa Sayıları: ss.1461-1471
  • Anahtar Kelimeler: Behcet's syndrome, epidemiology, pathogenesis, genetics, outcome measures, clinical findings, management, WALL THICKNESS, DISEASE, MULTICENTER, APREMILAST, DIAGNOSIS, FEATURES, UVEITIS, SINGLE, ULCERS
  • İstanbul Üniversitesi Adresli: Evet

Özet

This review highlights publications on different aspects of Behcet's syndrome (BS) that appeared in 2021 and pro-vides a critical view. These publications include works on the epidemiology of BS across different continents, newly developed instruments to assess damage in BS, studies highlighting the immunopathogenesis, genetics and epigenetic factors, histopathology of the pathergy lesion, clinical and imaging aspects of vascular involvement, and safety and efficacy of therapeutic agents including tocilizumab, apremi-last and direct oral anticoagulants.